Udine Wealth Management Inc. Makes New Investment in Oscar Health, Inc. $OSCR

Udine Wealth Management Inc. acquired a new position in shares of Oscar Health, Inc. (NYSE:OSCR) in the 2nd quarter, according to its most recent filing with the SEC. The fund acquired 61,472 shares of the company’s stock, valued at approximately $1,318,000. Oscar Health makes up 0.8% of Udine Wealth Management Inc.’s holdings, making the stock its 28th largest position.

Several other institutional investors and hedge funds have also made changes to their positions in OSCR. Nuveen LLC acquired a new position in shares of Oscar Health during the 1st quarter worth approximately $29,684,000. Thrive Capital Management LLC boosted its holdings in shares of Oscar Health by 33.4% during the 4th quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company’s stock worth $85,258,000 after purchasing an additional 1,588,395 shares during the last quarter. Vanguard Group Inc. boosted its holdings in shares of Oscar Health by 3.7% during the 1st quarter. Vanguard Group Inc. now owns 19,698,442 shares of the company’s stock worth $258,247,000 after purchasing an additional 700,469 shares during the last quarter. American Century Companies Inc. boosted its holdings in shares of Oscar Health by 50.0% during the 1st quarter. American Century Companies Inc. now owns 1,927,261 shares of the company’s stock worth $25,266,000 after purchasing an additional 642,057 shares during the last quarter. Finally, Assenagon Asset Management S.A. boosted its holdings in shares of Oscar Health by 3,878.8% during the 2nd quarter. Assenagon Asset Management S.A. now owns 599,488 shares of the company’s stock worth $12,853,000 after purchasing an additional 584,421 shares during the last quarter. 75.70% of the stock is currently owned by institutional investors and hedge funds.

Oscar Health Trading Down 8.4%

OSCR opened at $18.81 on Friday. Oscar Health, Inc. has a one year low of $11.20 and a one year high of $23.80. The stock has a market capitalization of $4.86 billion, a PE ratio of -23.22 and a beta of 1.89. The business’s 50 day moving average price is $17.77 and its 200 day moving average price is $15.86. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.86 and a current ratio of 0.86.

Oscar Health (NYSE:OSCR) last released its quarterly earnings results on Wednesday, August 6th. The company reported ($0.89) EPS for the quarter, topping analysts’ consensus estimates of ($0.90) by $0.01. Oscar Health had a negative return on equity of 13.78% and a negative net margin of 1.50%.The company had revenue of $2.86 billion for the quarter, compared to analysts’ expectations of $2.88 billion. During the same period in the prior year, the firm earned $0.20 earnings per share. The firm’s revenue was up 29.0% compared to the same quarter last year. As a group, equities research analysts expect that Oscar Health, Inc. will post 0.69 EPS for the current year.

Insider Buying and Selling

In other Oscar Health news, insider Mario Schlosser sold 395,000 shares of the company’s stock in a transaction on Monday, September 22nd. The stock was sold at an average price of $18.43, for a total transaction of $7,279,850.00. Following the transaction, the insider directly owned 501,148 shares in the company, valued at $9,236,157.64. This represents a 44.08% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 24.39% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

OSCR has been the topic of several recent research reports. Piper Sandler lowered their target price on Oscar Health from $14.00 to $13.00 and set a “neutral” rating on the stock in a report on Thursday, August 14th. Raymond James Financial cut Oscar Health from an “outperform” rating to a “market perform” rating in a report on Tuesday, June 24th. Robert W. Baird reiterated a “neutral” rating and issued a $14.00 price objective (down from $28.00) on shares of Oscar Health in a report on Friday, July 25th. UBS Group reiterated a “sell” rating and issued a $11.00 price objective (down from $15.00) on shares of Oscar Health in a report on Tuesday, July 15th. Finally, Wall Street Zen cut Oscar Health from a “hold” rating to a “sell” rating in a report on Saturday, August 9th. Four equities research analysts have rated the stock with a Hold rating and six have assigned a Sell rating to the company. According to MarketBeat.com, Oscar Health has an average rating of “Strong Sell” and a consensus price target of $12.64.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.